Search

everythinglearnresearchcommunity

for

Search:↓

Neurosteroids help control dopamine responses in the brain.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Obesity is linked to more severe hair loss in adult men and to excess hair growth, but its effects on hair conditions are complex and need more research.

Hormones significantly affect hair growth and loss, with potential for new treatments.

Inflammation linked to the immune response may play a role in causing various types of hair loss.

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

The document concludes that hair loss in women can be caused by various factors and is managed with specific treatments like medication, therapy, and lifestyle changes.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Early treatment is important for better hair regrowth in elderly women with hair loss.

CEC levels may be a useful marker for predicting prostate cancer progression.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

CAG repeat numbers in the AR gene likely don't affect male pattern baldness in Korean men.

Male pattern baldness is a genetic condition causing hair loss, with limited but improving treatment options.

Androgenetic alopecia is the most common hair loss, more severe in men, and best treated with a combination of hair growth promoters and antiandrogens.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

Polycystic Ovary Syndrome (PCOS) is a complex disorder with both immediate and long-term health effects, including menstrual issues, infertility, and increased risk of diabetes and heart disease.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Higher androgen receptor levels in bald areas may cause hair loss, while estrogen receptors have less impact.

The document emphasizes the need for surgeons to stay updated with the latest hair restoration and removal techniques and introduces new, essential information in the field.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Androgenetic alopecia is linked to family history and androgen effects.

Androgen receptor expression is similar in affected and unaffected scalp areas in androgenetic alopecia.

High levels of androgens can cause skin issues like acne, hair loss, and excessive hair growth.

Spironolactone effectively reduces symptoms of hyperandrogenism but has some side effects.

Different hair growth phases affect how follicles respond to X-rays, and hormones like testosterone and dihydrotestosterone play a key role in baldness; transplanted hair can grow on bald scalp areas.

Understanding androgen metabolism and thorough medical history are crucial for assessing and treating hair disorders.